Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Dextran Sulfate Sodium Salt (MW 35000-45000): Gold-Standa...

    2026-04-03

    Dextran Sulfate Sodium Salt (MW 35000-45000): Gold-Standard Inducer for Murine Colitis Models

    Executive Summary: Dextran sulfate sodium salt (DSS, MW 35000-45000; APExBIO SKU B8205) is a highly water-soluble, polyanionic sulfated polysaccharide routinely used as a chemical inducer of experimental colitis in mice and rats (product page). DSS disrupts the colonic epithelial barrier by inducing apoptosis, leading to acute and chronic inflammation that closely mimics human ulcerative colitis symptoms [Cell Death Dis. 2026]. The model is highly reproducible and sensitive to epithelial repair mechanisms and anti-inflammatory interventions. DSS also inhibits HIV-1 viral entry, supporting applications in virology [dexsp.com]. This article synthesizes the biological rationale, mechanisms, experimental parameters, and current research benchmarks for DSS-driven colitis and antiviral assays.

    Biological Rationale

    Ulcerative colitis (UC) is a chronic, relapsing inflammatory disorder of the colon and rectum, recognized as a challenging disease by the World Health Organization [Cell Death Dis. 2026]. Disruption of the intestinal mucosal barrier is the earliest pathological hallmark of UC, precipitating immune activation and tissue damage. In vivo models that faithfully recapitulate this process are essential for dissecting the roles of immune signaling, epithelial repair, and host-microbe interactions in IBD.

    DSS (MW 35000-45000) directly injures the colonic epithelium, triggering barrier dysfunction, apoptosis, and mucosal inflammation in rodents. This enables precise evaluation of epithelial repair pathways, such as the recently elucidated GPR35-KLF5 circuit, which governs intestinal epithelial cell (IEC) proliferation and migration during mucosal healing [Cell Death Dis. 2026]. The DSS-induced colitis model is widely regarded as the gold standard for preclinical IBD research because of its reproducibility, scalability, and phenotypic resemblance to human UC [dexsp.com].

    Mechanism of Action of Dextran sulfate sodium salt (MW 35000-45000)

    DSS (MW 35000-45000) consists of sulfated glucose polymers, conferring a strong negative charge and high water solubility (≥55.5 mg/mL at room temperature) [APExBIO]. Upon oral administration (typically 2.5–5% w/w in drinking water), DSS is not metabolized by the host but instead acts locally in the colon:

    • Direct epithelial toxicity: DSS disrupts the colonic mucosal barrier by inducing apoptosis of IECs and compromising tight junctions, leading to increased permeability and translocation of luminal contents [disodiumsalt.com].
    • Immune activation: Barrier loss exposes submucosal immune cells (macrophages, neutrophils, dendritic cells) to microbial products, triggering robust inflammatory cascades.
    • Repair mechanisms: DSS-induced injury initiates epithelial repair programs, notably involving GPR35 sensing of tryptophan metabolites and KLF5-driven gene networks orchestrating IEC proliferation and migration [Cell Death Dis. 2026].
    • Antiviral activity: DSS impedes viral adsorption and entry, especially HIV-1, by interfering with virus-cell surface interactions, without significant effects on blood coagulation [dexsp.com].

    These features distinguish DSS from other chemical inducers by enabling selective, repeatable modeling of both acute and chronic colonic inflammation.

    Evidence & Benchmarks

    • DSS (MW 35000-45000) administered at 2.5–5% (w/w) in murine drinking water reproducibly induces acute colitis within 5–7 days, characterized by weight loss, diarrhea, and histological mucosal damage (Cell Death Dis. 2026).
    • DSS-induced colitis recapitulates key features of human UC, including epithelial apoptosis, crypt loss, and leukocyte infiltration (dexsp.com).
    • Disruption of GPR35-KLF5-dependent signaling impairs epithelial repair in DSS models, delaying mucosal healing (Cell Death Dis. 2026).
    • DSS inhibits HIV-1 replication in cell culture by blocking viral entry, supporting dual use in virology (dexsp.com).
    • The B8205 kit from APExBIO provides a standardized, quality-controlled DSS source for reproducible colitis and viral inhibition studies (APExBIO).
    • Protocol optimization (e.g., batch consistency, solution freshness) is critical for experimental reliability (igg-light-chain-variable-region.com).

    Applications, Limits & Misconceptions

    DSS (MW 35000-45000) is widely applied in:

    • Acute and chronic murine colitis modeling: Enables dissection of inflammatory and repair pathways, including drug testing and genetic studies.
    • Evaluation of anti-inflammatory and immunomodulatory therapies: Serves as a benchmark for preclinical therapeutic efficacy.
    • Host-pathogen interaction studies: Models how epithelial integrity influences microbial translocation and immune activation.
    • Antiviral research: Used for in vitro HIV-1 entry inhibition and related mechanistic studies.

    For expanded mechanistic discussion and translational strategy, see Redefining Intestinal Inflammation Models—this article updates those insights with recent findings on epithelial repair circuits and protocol optimization. For practical workflow guidance, this scenario-driven article details reproducibility checkpoints and laboratory troubleshooting, which this review further contextualizes with new evidence.

    Common Pitfalls or Misconceptions

    • DSS-induced colitis is not an infectious model: DSS does not introduce exogenous pathogens; effects are due to chemical injury.
    • Batch-to-batch variability: Variations in molecular weight or sulfate content can affect potency; use validated lots (e.g., B8205 from APExBIO).
    • Limited systemic modeling: DSS primarily affects the colon, with minimal small intestine or systemic involvement.
    • Not suitable for long-term solution storage: DSS solutions should be freshly prepared; degradation or precipitation can impair reproducibility.
    • Does not recapitulate all IBD mechanisms: DSS models epithelial injury/inflammation, but not immune-initiated or genetic forms of IBD.

    Workflow Integration & Parameters

    DSS (MW 35000-45000) is supplied as a solid and should be stored at room temperature in a desiccated environment. Key workflow considerations:

    • Preparation: Dissolve DSS in distilled water (≥55.5 mg/mL); do not use ethanol or DMSO.
    • Administration: Typical in vivo dosing is 2.5–5% (w/w) in drinking water for 5–7 days to induce acute colitis; chronic models use cycles of DSS and water.
    • Controls: Include water-only controls and, where possible, batch-matched DSS for consistency.
    • Monitoring: Record body weight, stool consistency, and rectal bleeding daily; harvest tissue for histological analysis at endpoint.
    • Solution stability: Prepare fresh DSS solutions prior to each experiment; avoid prolonged storage to prevent loss of potency.

    For more on protocol troubleshooting and lab best practices, see Reliable Inflammation and Virology Modeling. This article adds updated guidelines on solution handling and batch validation.

    Conclusion & Outlook

    DSS (MW 35000-45000) remains the gold-standard chemical inducer for modeling colitis and epithelial barrier disruption in rodents. Its robust mechanism—direct epithelial toxicity, apoptosis induction, and barrier compromise—enables faithful recapitulation of human UC and facilitates discovery of epithelial repair pathways, such as the GPR35-KLF5 circuit [Cell Death Dis. 2026]. The B8205 kit from APExBIO delivers batch-controlled DSS for reproducible research in IBD, anti-inflammatory drug discovery, and HIV-1 inhibition. Ongoing protocol refinement and mechanistic insight will further enhance the translational value of DSS-based models for gastrointestinal and virology research.

    For a comparative analysis of DSS and other colitis inducers, see Mechanistic and Strategic Guidance—this article clarifies DSS-specific advantages and boundaries for translational research.